FDA and NIH Announcements on Autism

The segment dives into significant FDA and NIH announcements, including a new autism treatment (Leucovorin) and updated acetaminophen warnings. BKP praises Trump’s bold leadership in prioritizing children’s health and criticizes the media for ignoring these developments in favor of attacking Trump.

FDA and NIH Developments:
FDA approves Leucovorin for autism treatment, a major step not covered by mainstream media.
NIH launches a $1 million autism research initiative with 250 teams studying root causes, focusing on environmental and genetic factors.
FDA updates acetaminophen labels to warn pregnant women of potential neurodevelopmental risks, backed by studies from Johns Hopkins, Yale, and Harvard.
Expert Insights:
Dr. Marty McCary (FDA) emphasizes a historic shift in medical culture, prioritizing root causes over corporate interests.
Dr. Fink (pediatrician) encourages parents to consult doctors and take minimal acetaminophen doses during pregnancy.
Dr. Oz highlights the need to spread out vaccine doses to reduce potential risks to infants.
Media Suppression:
Networks like CNN and MSNBC ignore FDA/NIH announcements, focusing instead on Trump’s Tylenol comments and mispronunciations.
Sanjay Gupta (CNN) dismisses Tylenol-autism links, citing “decades of evidence” without addressing new studies.
Global Context:
Mentions UN assembly, Macron’s two-state solution support, and rising global tensions, urging viewers to stay vigilant.